Paper Title
Evaluation of antimicrobial utilization for dirrheal diseases treatment among under five patients
Article Identifiers
Authors
Beyene tola sheri , Assebe Zemdkun , Balkew Yimeru , Tigist Girma , Ayenachew Bayu
Keywords
Antimicrobial use for diarrheal diseases among under five patients.
Abstract
Executive Summary Introduction: Diarrhea is defined as passage of 3 or more unusually loose stool or watery stool of any frequency within 24 hours and became second cause of death in under-5-year children globally. Antimicrobial agents are among the most used therapeutics and widely misused of all drugs. These irrational and uncontrollable uses of antibiotics will increases resistance, potential adverse effects and cost. Objective: This study was aimed to evaluate antimicrobial utilization for diarrheal diseases among under-5 out-patients based on IMNCI criteria at Semen health center in Arada sub city of Addis Ababa the capital city of Ethiopia in 2023. Methods: An institutional-based retrospective descriptive cross-sectional study was employed using medication records of under-5 out-patients who treated for diarrheal diseases in 2023 at Semen health center from January 1, 2023 to December 30, 2023. A total of 75 diarrheal diseases treatment records were investigated. Systematic random samplings were employed to collect the required sample from the sampling frame. The collected data was entered into excel statistical data analyzer and computed using descriptive analysis. Descriptive statistics and cross tabulation was carried out, and the result was presented using texts, tables, and graphs. Results: From the total 75 diarrheal diseases treated the overall indications (n=71, 94.67%), dose, strength, frequency band duration (n=67, 89.33%) each and both drug-drug interaction and contra-indication (n=75,100%) were correctly prescribed. Conclusion: This study revealed that antimicrobial use for diarrheal diseases treatment was slightly deviated from criteria and threshold while other medication for diarrheal treatment such as ORS and metoclopramide more deviated from the criteria.
Downloads
How To Cite (APA)
Beyene tola sheri, Assebe Zemdkun, Balkew Yimeru, Tigist Girma, & Ayenachew Bayu (June-2024). Evaluation of antimicrobial utilization for dirrheal diseases treatment among under five patients. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(6), c204-c214. https://ijnrd.org/papers/IJNRD2406219.pdf
Issue
Volume 9 Issue 6, June-2024
Pages : c204-c214
Other Publication Details
Paper Reg. ID: IJNRD_221661
Published Paper Id: IJNRD2406219
Downloads: 000121989
Research Area: Pharmacy
Country: Addis Ababa, Addis ababa, Ethiopia
Published Paper PDF: https://ijnrd.org/papers/IJNRD2406219.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2406219
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.
Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: October 2025
Current Issue: Volume 10 | Issue 10 | October 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Oct-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
